您的位置: 首页 > 农业专利 > 详情页

SYSTÈME D'ADMINISTRATION À LIBÉRATION IMMÉDIATE/RETARDÉE EN COMBINAISON POUR DES MÉDICAMENTS À COURTE DEMI-VIE COMPRENANT DE LA RÉMOGLIFLOZINE
专利权人:
INC.;BHV PHARMA
发明人:
GREEN, JAMES, TRINCA,WILKISON, WILLIAM, OWEN
申请号:
EP11804320
公开号:
EP2590634A4
申请日:
2011.07.07
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
A combination immediate/delayed release delivery system for compounds which have short half-life's, such as the antidiabetic remogliflozin etabonate, is provided which provides a dosage form that has two distinct phases of release, a formulation that promotes immediate release of the compound upon ingestion and another formulation which delays the release of the compound so that a dosing regimen of remogliflozin etabonate, once daily, may be achieved while providing effective control of plasma glucose and minimizing the nighttime exposure of this compound. The delivery system includes, but is not limited to, a combination of enteric coating of an immediate release formulation such that a delay in release is provided. Methods for forming the so-described immediate/delayed release delivery system and using such delivery system for treating diabetes are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充